Maynooth University's Kathleen Londsdale Institute for Human Health Research has just published research into the benefits of the popular obesity treatment drug, GLP-1.
, in part due to their anticancer immune cells—better known as the 'Natural Killer ' cell—being rendered useless due to their disease.
The World Health Organization estimates that 13% of the global adult population suffers from obesity; a disease linked with a higher risk of getting cancer. These cancers make up 40% of all cancers diagnosed in the United States each year., also shows that the restored cancer-killing effect of NK cells is independent of the GLP-1's main weight loss function so it appears the treatment is directly kick-starting the NK cells' engine.
"While these findings will understandably be welcomed by those living with obesity and looking for safe and effective treatments, given the recent spike in popularity related to the benefits of the GLP-1 treatment with global and high-profile celebrities commenting on its success, global demand has increased and resulted in a worldwide shortage of the drug.
Belgique Dernières Nouvelles, Belgique Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
White House pledges $140 million for new AI research centersPlus: Hollywood writers go on strike to fight against AI stealing their jobs, and more
Lire la suite »
7 things you could buy with the $30B Meta has lost to VR and AR researchIs Twitter discounted yet?
Lire la suite »
ChatGPT: Can students pass using AI tools at university?There are fears about cheating, but new advice says students should be taught how to use AI tools.
Lire la suite »
U.S. Backs Study of Safe Injection Sites to Prevent Drug OverdosesFor the first time, the U.S. government will pay for a large study measuring whether overdoses can be prevented by so-called safe injection sites
Lire la suite »
AI predicts future pancreatic cancerAn artificial intelligence tool has successfully identified people at the highest risk for pancreatic cancer up to three years before diagnosis using solely the patients' medical records, according to new research led by investigators at Harvard Medical School and the University of Copenhagen, in collaboration with VA Boston Healthcare System, Dana-Farber Cancer Institute, and the Harvard T.H. Chan School of Public Health.
Lire la suite »
Can intermittent fasting tackle obesity-related inflammation?Research reviews the effects of two forms of intermittent fasting, time-restricted eating (TRE) and alternate-day fasting (ADF), on body weight and key circulating inflammatory markers (CRP, TNF-alpha, and IL-6) in adults with obesity. The results suggest that intermittent fasting has little or no effect on key inflammatory markers, but more research is needed to confirm these findings.
Lire la suite »